PATENT CLAIM ANALYSIS

Application Number: 15860761
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["424", "142100"]

Abstract:
Disclosed here are methods and systems for improving the aggregation profile in a liquid antibody formulation. In one embodiment, the antibody is a fully monoclonal antibody that binds to Angiopoietin-2.

Claim (Index 14):
The liquid antibody formulation of  claim 13 , wherein the surfactant is a nonionic surfactant selected from polysorbate, poloxamer and combinations thereof.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 86.0
- Lexical Diversity: 1.17857
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14114835', '11311939', '14486050', '12572289', '14192213']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.75458755420356
- 35 USC 102 Novelty (BERT): 0.5248116171867874
- Combined Prediction Score: 0.7316099605018829
- Mean Citation Score: 318.553998
- Max Citation Score: 324.9216600000001
- Similarity Product: 208.55003612740524

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test